4.7 Article

CREB Downregulation in Vascular Disease A Common Response to Cardiovascular Risk

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.109.199133

关键词

atherosclerosis; insulin resistance; CREB; LDL; vascular smooth muscle

资金

  1. VA Merit
  2. Merck Investigator-initiated research support
  3. BIRCWH K12
  4. [DK64741]
  5. [HL56481]
  6. [P30 DK035816]

向作者/读者索取更多资源

Objective-To examine the impact of low-density lipoprotein (LDL), an established mediator of atherosclerosis, on the transcription factor cAMP-response element-binding protein (CREB), which is a regulator of vascular smooth muscle cell (VSMC) quiescence. Methods and Results-VSMC CREB content is diminished in rodent models of diabetes and pulmonary hypertension. We examined aortic CREB content in rodent models of aging, hypertension, and insulin resistance, and we determined nuclear CREB protein in the medial VSMC of high-fat-fed LDL receptor-null mice. There was significant loss of CREB protein in all models. In vitro, primary culture rat aortic VSMC exposed to LDL and oxidized LDL exhibited a rapid, transient increase in CREB phosphorylation and transient phosphorylation/activation of Akt, ERK, JNK, ans p38 MAPK. Exposure to oxidized LDL, but not to LDL, for 24 to 48 hours decreased CREB protein in a dose-dependent fashion and led to nuclear exclusion of CREB. Pharmacological reactive oxygen species scavengers and inhibition of ERK activation blocked oxidized LDL-mediated CREB downregulation. Conclusion-These data support a model wherein loss of VSMC CREB protein, which renders these cells more susceptible to activation and apoptosis, is a common pathological response to vascular injury and potentially contributes to plaque progression. (Arterioscler Thromb Vasc Biol. 2010; 30: 733-741.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Physiology

Chronic hindbrain administration of oxytocin elicits weight loss in male diet-induced obese mice

Melise M. Edwards, Ha K. Nguyen, Adam J. Herbertson, Andrew D. Dodson, Tomasz Wietecha, Tami Wolden-Hanson, James L. Graham, Kevin D. O'Brien, Peter J. Havel, James E. Blevins

Summary: Chronic hindbrain oxytocin (OT) treatment leads to sustained weight loss in diet-induced obese (DIO) mice by reducing energy intake and increasing brown adipose tissue (BAT) thermogenesis at a dosage that does not cause visceral illness.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2021)

Editorial Material Endocrinology & Metabolism

The Evolution of Hemoglobin A1c Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence

Maria J. Redondo, Ingrid Libman, David M. Maahs, Sarah K. Lyons, Mindy Saraco, Jane Reusch, Henry Rodriguez, Linda A. DiMeglio

Summary: The American Diabetes Association 2020 Standards of Medical Care in Diabetes recommend setting individualized A1C targets for children with type 1 diabetes, emphasizing the detrimental effects of hyperglycemia in children and adolescents. It is suggested that the use of newer insulins and devices may reduce the risk of severe hypoglycemia.

DIABETES CARE (2021)

Article Hematology

Sexually Dimorphic Relationships Among Saa3 (Serum Amyloid A3), Inflammation, and Cholesterol Metabolism Modulate Atherosclerosis in Mice

Alan Chait, Shari Wang, Leela Goodspeed, Diego Gomes, Katherine E. Turk, Tomasz Wietecha, Jingjing Tang, Carl Storey, Kevin D. O'Brien, Katya B. Rubinow, Chongren Tang, Tomas Vaisar, Sina A. Gharib, Aldons J. Lusis, Laura J. Den Hartigh

Summary: Saa3 promotes atherosclerosis in male mice but is atheroprotective in female mice, which may be related to sex-specific relationships between Saa3, sex steroid signaling, inflammatory genes, and Trem2 macrophages.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Review Peripheral Vascular Disease

Acute effects of sedentary breaks on vascular health in adults at risk for type 2 diabetes: A systematic review

Mary O. Whipple, Kevin S. Masters, Amy G. Huebschmann, Rebecca L. Scalzo, Jane E. B. Reusch, Audrey Bergouignan, Judith G. Regensteiner

Summary: This systematic review evaluates the acute effects of interrupting prolonged sedentary behavior on vascular health among individuals at risk for type 2 diabetes. The evidence suggests that light and moderate intensity activity breaks can acutely lower blood pressure, but further research is needed to understand the impact on other vascular outcomes.

VASCULAR MEDICINE (2021)

Article Hematology

Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects

Graziella E. Ronsein, Tomas Vaisar, W. Sean Davidson, Karin E. Bornfeldt, Jeffrey L. Probstfield, Kevin D. O'Brien, Xue-Qiao Zhao, Jay W. Heinecke

Summary: Niacin therapy does not reduce cardiovascular events in statin-treated subjects, despite increasing HDL-C levels and decreasing LDL-C and triglyceride levels. The addition of niacin to statin therapy results in elevated levels of multiple HDL proteins linked to increased atherosclerotic risk, potentially compromising the cardioprotective effects associated with higher HDL-C levels and lower levels of LDL-C and triglycerides.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Editorial Material Endocrinology & Metabolism

Career Advancement for Women in Diabetes-Related Research: Developing and Retaining Female Talent

Darleen A. Sandoval, Laura C. Alonso, Maureen Gannon, Maike Sander, Lori Sussel, Jane E. B. Reusch

DIABETES CARE (2021)

Article Biochemistry & Molecular Biology

Comparison between genetic and pharmaceutical disruption of Ldlr expression for the development of atherosclerosis

Diego Gomes, Shari Wang, Leela Goodspeed, Katherine E. Turk, Tomasz Wietecha, Yongjun Liu, Karin E. Bornfeldt, Kevin D. O'Brien, Alan Chait, Laura J. den Hartigh

Summary: Ldlr-ASO is a promising tool for generating complex rodent models of atherosclerosis, but it does not induce comparable levels of hypercholesterolemia or atherosclerosis as Ldlr(-/-) mice and increases hepatic inflammation.

JOURNAL OF LIPID RESEARCH (2022)

Article Urology & Nephrology

Patient-Reported Symptoms and Subsequent Risk of Myocardial Infarction in Chronic Kidney Disease

Benjamin Lidgard, Leila R. Zelnick, Kevin D. O'Brien, Nisha Bansal

Summary: In a large ambulatory cohort of adults with CKD, symptoms of atherosclerotic cardiovascular disease were strongly associated with a higher risk for subsequent myocardial infarction, including chest pain and shortness of breath.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Cardiac & Cardiovascular Systems

Framingham and American College of Cardiology/American Heart Association Pooled Cohort Equations, High-Sensitivity Troponin T, and N-Terminal Pro-Brain-Type Natriuretic Peptide for Predicting Atherosclerotic Cardiovascular Events Across the Spectrum of Kidney Dysfunction

Benjamin Lidgard, Leila R. Zelnick, Alan Go, Kevin D. O'Brien, Nisha Bansal

Summary: This study aimed to evaluate the effectiveness of atherosclerotic cardiovascular disease screening tools and clinically available cardiac biomarkers in guiding primary prevention in patients with chronic kidney disease. The results showed that the Framingham Risk Score and the Pooled Cohort Equation had moderate discrimination in predicting atherosclerotic cardiovascular disease, and the addition of hsTnT improved their discrimination. However, N-terminal pro-brain-type natriuretic peptide did not significantly improve the discrimination of the risk scores.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Editorial Material Hematology

Lipoproteins and Calcific Aortic Valve Disease: Hardening Evidence?

Kevin D. O'Brien

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

Right heart failure after left ventricular assist device: From mechanisms to treatments

Claudio A. Bravo, Andrew G. Navarro, Karanpreet K. Dhaliwal, Maziar Khorsandi, Jeffrey E. Keenan, Parvathi Mudigonda, Kevin D. O'Brien, Claudius Mahr

Summary: Left ventricular assist device (LVAD) therapy is a life-saving option for patients with advanced heart failure who do not respond to medical treatment. However, a significant percentage of LVAD patients develop right heart failure (RHF), which is associated with poor outcomes. The mechanisms of RHF are complex, involving patient factors, surgical factors, and hemodynamic factors. Despite advances in surgical techniques and LVAD technology, RHF remains a major cause of morbidity and mortality among LVAD patients. Current medical therapies for RHF are limited, and cardiac transplantation or supportive management are the only options for these patients. Efforts to predict the risk of RHF in LVAD patients have been challenging, with varying definitions of RHF in different studies. Additionally, most research in this field has focused on early-onset RHF, while late-onset RHF is increasingly recognized as a significant problem. This review aims to describe the unique physiology of the right ventricle and the changes caused by LVADs that may contribute to both early- and late-onset RHF. The available treatments for RHF, including mechanical circulatory support and medical therapies, will also be analyzed.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction

Dennis D. Wang, Sophia E. Airhart, Bo Zhou, Laura M. Shireman, Siyi Jiang, Carolina Melendez Rodriguez, James N. Kirkpatrick, Danny D. Shen, Rong Tian, Kevin D. O'Brien

Summary: Mitochondrial dysfunction in heart failure is associated with changes in NAD(+) and NADH levels. Raising NAD(+) levels using nicotinamide riboside (NR) may be a promising treatment for heart failure. In a trial involving 30 clinically stable heart failure patients, NR at a dose of 1,000 mg twice daily was found to be safe and well tolerated, and it approximately doubled whole blood NADthorn levels. The increase in NAD(+) in response to NR correlated with improved peripheral blood mononuclear cell respiration and reduced NLRP3 expression.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2022)

Article Cardiac & Cardiovascular Systems

Magnetic Resonance Imaging of Intraplaque Hemorrhage and Plaque Lipid Content With Continued Lipid-Lowering Therapy: Results of a Magnetic Resonance Imaging Substudy in AIM-HIGH

Xue-Qiao Zhao, Jie Sun, Daniel S. Hippe, Daniel A. Isquith, Gador Canton, Kiyofumi Yamada, Niranjan Balu, John R. Crouse, Todd J. Anderson, John Huston, Kevin D. O'Brien, Thomas S. Hatsukami, Chun Yuan

Summary: This study examined the impact of intraplaque hemorrhage (IPH) on lipid content change in the setting of intensive lipid-lowering therapy. The results indicate that IPH significantly affects lipid content change and is associated with plaque stability.

CIRCULATION-CARDIOVASCULAR IMAGING (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

Late Presentation Right Ventricular Failure in Patients With Left Ventricular Assist Device

Andrew G. Navarro, Antonio Olivas-Martinez, Lorenzo Braghieri, Song Li, Claudius Mahr, Rong Tian, Kevin D. O'Brien, Claudio A. Bravo

CIRCULATION (2022)

Letter Urology & Nephrology

Kidney Tubular Injury Biomarkers and Secretory Function in Acute Decompensated Heart Failure

Alexander J. Kula, David K. Prince, Bryan R. Kestenbaum, Song Li, Kevin D. O'Brien, Nisha Bansal

KIDNEY MEDICINE (2022)

暂无数据